Prevalence and incidence of hypertension: Results from a representative cohort of over 16,000 adults in three cities of South Asia

Indian Heart Journal

Volumn 69, Issue 4, 2017, Pages 434-441

  Prabhakaran, Dorairaj ^a,b   Jeemon, Panniyammakal ^a,b   Ghosh, Shreeparna ^a,b   Shivashankar, Roopa ^a,b   Ajay, Vamadevan S ^a,b   Kondal, Dimple ^a,b   Gupta, Ruby ^a,b   Ali, Mohammed K ^b,c   Mohan, Deepa ^d   Mohan, Viswanathan ^d   Kadir, Masood M ^e   Tandon, Nikhil ^b,f   Reddy, Kolli Srinath ^a,b   Narayan, K M Venkat ^b,c  

^a PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^b Centre for Control of Chronic Conditions   (India)

^c EMORY UNIVERSITY   (United States)

^d MADRAS DIABETES RESEARCH FOUNDATION   (India)

^e AGA KHAN UNIVERSITY   (Pakistan)

^f ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Hypertension; Incidence; India; Prevalence; South Asia

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; ATTRIBUTABLE RISK; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DYSGLYCEMIA; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INCIDENCE; INDIA; INFORMED CONSENT; MALE; OBESITY; PAKISTAN; POPULATION RESEARCH; PREVALENCE; RISK FACTOR; SOCIAL STATUS; SYSTOLIC BLOOD PRESSURE; AGE; ASIA; BLOOD PRESSURE; CITY; CLINICAL TRIAL; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX RATIO; URBAN POPULATION;

ADULT; AGE FACTORS; ASIA; BLOOD PRESSURE; CITIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; MALE; PREVALENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; URBAN POPULATION;

EID: 85020714161     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ihj.2017.05.021     Document Type: Article

References (31)

1. Poulter, N.R., Prabhakaran, D., Caulfield, M., Hypertension. Lancet 386:9995 (2015), 801–812.
2. Kearney, P.M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P.K., He, J., Global burden of hypertension: analysis of worldwide data. Lancet 365:9455 (2005), 217–223.
3. Collaborators GBDRF, Forouzanfar, M.H., Alexander, L., et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the global burden of disease study 2013. Lancet 386:10010 (2015), 2287–2323.
4. Arima, H., Barzi, F., Chalmers, J., Mortality patterns in hypertension. J Hypertens 29:Suppl. 1 (2011), S3–7.
5. Danaei, G., Finucane, M.M., Lin, J.K., et al. National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants. Lancet 377:9765 (2011), 568–577.
6. Anchala, R., Kannuri, N.K., Pant, H., et al. Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension. J Hypertens 32:6 (2014), 1170–1177.
7. Dodani, S., Mistry, R., Khwaja, A., Farooqi, M., Qureshi, R., Kazmi, K., Prevalence and awareness of risk factors and behaviours of coronary heart disease in an urban population of Karachi, the largest city of Pakistan: a community survey. J Public Health (Oxf) 26:3 (2004), 245–249.
8. Rahman, M.M., Gilmour, S., Akter, S., Abe, S.K., Saito, E., Shibuya, K., Prevalence and control of hypertension in Bangladesh: a multilevel analysis of a nationwide population-based survey. J Hypertens 33:3 (2015), 465–472 discussion 472.
9. Ettehad, D., Emdin, C.A., Kiran, A., et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 387:10022 (2016), 957–967.
10. Law, M.R., Morris, J.K., Wald, N.J., Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ, 338, 2009, b1665.
11. Gupta, R., Misra, A., Vikram, N.K., et al. Younger age of escalation of cardiovascular risk factors in Asian Indian subjects. BMC Cardiovasc Disord, 9, 2009, 28.
12. Jeemon, P., Prabhakaran, D., Goenka, S., et al. Impact of comprehensive cardiovascular risk reduction programme on risk factor clustering associated with elevated blood pressure in an Indian industrial population. Indian J Med Res 135:4 (2012), 485–493.
13. Nair, M., Ali, M.K., Ajay, V.S., et al. CARRS Surveillance study: design and methods to assess burdens from multiple perspectives. BMC public health, 12, 2012, 701.
14. The WHO STEPwise approach to noncommunicable disease risk factor surveillance (STEPS). Geneva World Health Organization, 2002.
15. James, P.A., Oparil, S., Carter, B.L., et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311:5 (2014), 507–520.
16. Ali, M.K., Bhaskarapillai, B., Shivashankar, R., et al. Socioeconomic status and cardiovascular risk in urban South Asia: The CARRS Study. Eur J Prev Cardiol 23:4 (2016), 408–419.
17. Levey, A.S., Stevens, L.A., Schmid, C.H., et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 150:9 (2009), 604–612.
18. Deepa, M., Grace, M., Binukumar, B., et al. High burden of prediabetes and diabetes in three large cities in South Asia: the Center for cArdio-metabolic Risk Reduction in South Asia (CARRS) Study. Diabetes Res Clin Pract 110:2 (2015), 172–182.
19. Bhansali, A., Dhandania, V.K., Deepa, M., et al. Prevalence of and risk factors for hypertension in urban and rural India: the ICMR-INDIAB study. J Hum Hypertens 29:3 (2015), 204–209.
20. Mohan, V., Deepa, M., Farooq, S., Datta, M., Deepa, R., Prevalence, awareness and control of hypertension in Chennai – the Chennai urban rural epidemiology study (CURES-52). J Assoc Physicians India 55 (2007), 326–332.
21. Tu, K., Chen, Z., Lipscombe, L.L., Canadian hypertension education program outcomes research T: prevalence and incidence of hypertension from 1995 to 2005: a population-based study. CMAJ 178:11 (2008), 1429–1435.
22. Hajjar, I., Kotchen, J.M., Kotchen, T.A., Hypertension: trends in prevalence, incidence, and control. Annu Rev Public Health 27 (2006), 465–490.
23. Jayawardena, R., Ranasinghe, P., Byrne, N.M., Soares, M.J., Katulanda, P., Hills, A.P., Prevalence and trends of the diabetes epidemic in South Asia: a systematic review and meta-analysis. BMC Public Health, 12, 2012, 380.
24. Shah, S.M., Loney, T., Sheek-Hussein, M., et al. Hypertension prevalence, awareness, treatment, and control, in male South Asians immigrants in the United Arab Emirates: a cross-sectional study. BMC Cardiovasc Disord, 15(1), 2015, 30.
25. Gupta, R., Sharma, K.K., Gupta, A., et al. Persistent high prevalence of cardiovascular risk factors in the urban middle class in India: Jaipur Heart Watch-5. J Assoc Physicians India 60 (2012), 11–16.
26. Wang, L., Szklo, M., Folsom, A.R., Cook, N.R., Gapstur, S.M., Ouyang, P., Endogenous sex hormones, blood pressure change, and risk of hypertension in postmenopausal women: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 224:1 (2012), 228–234.
27. Misra, A., Ethnic-Specific criteria for classification of body mass index: a perspective for asian indians and american diabetes association position statement. Diabetes Technol Ther 17:9 (2015), 667–671.
28. Prabhakaran, D., Jeemon, P., Reddy, K.S., Commentary Poverty and cardiovascular disease in India: do we need more evidence for action?. Int J Epidemiol 42:5 (2013), 1431–1435.
29. Jeemon, P., Socio-economic status and cardiovascular risk among Indians. Prev Med 52:6 (2011), 471–472.
30. Subramanian, S.V., Corsi, D.J., Subramanyam, M.A., Smith, G.D., Jumping the gun: the problematic discourse on socioeconomic status and cardiovascular health in India. Int J Epidemiol 42:5 (2013), 1410–1426.
31. McManus, R.J., Caulfield, M., Williams, B., National institute for H, clinical E: NICE hypertension guideline 2011: evidence based evolution. BMJ, 344, 2012, e181.